As of April 16, 2025, Regencell Bioscience (RGC) has a market cap of $0.42 billion USD. According to our data, Regencell Bioscience is ranked No.6154 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.42 B |
553.44%
|
Dec 31, 2024 | $64.28 M |
-52.95%
|
Dec 29, 2023 | $0.14 B |
-62.35%
|
Dec 30, 2022 | $0.36 B |
-12.43%
|
Dec 31, 2021 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() COMPASS Pathways
CMPS
|
$0.28 B |
-0.000 M
|
![]() UK
|
![]() Atai Life Sciences
ATAI
|
$0.28 B |
0.000 M
|
![]() Germany
|
![]() Cybin
CYBN
|
$0.16 B |
0.000 M
|
![]() Canada
|
![]() Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
![]() USA
|
![]() GH Research
GHRS
|
$0.56 B |
-0.000 M
|
![]() Ireland
|
Market Cap | = | RGC Stock Price | * | RGC Shares Outstanding |
= | $32.28 | * | 13.01 M | |
= | $0.42 B |